Completed NA INTERVENTIONAL NCT00027404

Study of Fluoxetine in Adults With Autistic Disorder

Fluoxetine vs Placebo in Adult Autistic Disorder

Sponsor: Icahn School of Medicine at Mount Sinai

Interventions Fluoxetine

Updated 5 times since 2017 Last updated: Mar 24, 2015 Started: Sep 30, 2001 Completion: Aug 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00027404, this NA trial focuses on Autistic Disorder and remains completed. Sponsored by Icahn School of Medicine at Mount Sinai, it has been updated 5 times since 2001, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Icahn School of Medicine at Mount Sinai

Data source: FDA Office of Orphan Products Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States